TY  - CONF

T1  - Enhancement and Size-based Response Criteria for Evaluating Tyrosine Kinase Inhibitor Dosing Strategy in Metastatic Renal Cancer: Prospective Imaging Study from the UK STAR Trial

JO  - CLINICAL ONCOLOGY

PY  - 2024/01/01

AU  - Manickavasagar T

AU  - Kelly-Morland C

AU  - Wah TM

AU  - Nathan P

AU  - Brown J

AU  - Goh V

ED  - 

VL  - 36

IS  - 1

SP  - E78

EP  - E79

Y2  - 2024/12/22

ER  -